Top news of the week: 24.03.2022.
Career And Jobs
Torsten Buergermeister Joins VERAXA Biotech GmbH as Chief Financial Officer
The new CFO brings extensive experience in finance and business development at life science, pharma and technology companies.HEIDELBERG, Germany, March 22, 2022 / B3C newswire / -- Torsten ...
Greg Verdine will have many new C-suite friends at fungus biotech LifeMine after GSK-fueled $175M round
A year after securing funds from Rick Klausner and adding Nobel laureate William Kaelin to the board, fungus-focused LifeMine Therapeutics is ready to reveal the Big Pharma partner it’s ...
Merck development chief Roy Baynes is stepping out and reuniting with Roger Perlmutter at a biotech startup
Roger Perlmutter is bringing along more than a stellar reputation from Merck for his next career chapter in biotech. We learned this morning that Roy Baynes, his right-hand man in charge of ...
CBC Fellows Program Funds Life Sciences Entrepreneurs in Chicago
The Chicago Biomedical Consortium (CBC) launched the inaugural class of the CBC Entrepreneurial Fellows program to help train the next generation of Chicago bio-entrepreneurs.
He Left MIT At 22 To Solve A Problem Investors Didn’t Get. Now His Company Is Worth $6 Billion
Sajith Wickramasekara worked as a research assistant during his high school years and realized R&D relied too heavily on pens and paper. So he built Benchling, now worth $6 billion and ...
AnaptysBio CEO abruptly resigns less than a week after mid-stage flop
Less than a week after AnaptysBio dropped another indication for its lead drug, the biotech’s longtime CEO has decided to tap out. Hamza Suria tendered his resignation on Sunday, AnaptysBio ...
Toxys Opens US Office and Production Facility to Accelerate Growth
Toxys Opens US Office and Production Facility to Accelerate GrowthOEGSTGEEST, the Netherlands, March 16, 2022 / B3C newswire / -- Toxys BV, a Dutch biotech company that offers a broad ...
DEFENCE THERAPEUTICS: AN ANTI-CANCER SOLUTIONS PLATFORM COMPANY ADVANCING ITS VERSATILE ACCUM TECHNOLOGY
DGAP-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous22.03.2022 / 08:30 The issuer is solely responsible for the content of this announcement.CSE: DTC FSE: DTC USOTC: DTCFF ...